Nov. 20, 2024In the clinic for Nov. 20, 2024Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aelis, Biogen, Bridgebio, Brii, Cardiol, Chemomab, Eli Lilly, Esperion, Genethon, GSK, Immunitybio, Incyte, Merck, Newamsterdam, Nicox, Ocugen, Pliant, Protagonist, Regenxbio, Rocket, Silence, Thermosome, Vir.
Nov. 20, 2024In the clinic for November 20, 2024Clinical updates, including trial initiations, enrollment status and data readouts and publications: Brainsway.
Nov. 19, 2024In the clinic for Nov. 19, 2024Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adverum, Alnylam, Anthos, Arbutus, Bridgebio, Cybin, Eli Lilly, Intellia, Neurogene.